{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:20:33Z","timestamp":1791231633948,"version":"4.1.0"},"reference-count":124,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Several lines of evidence have clearly indicated that inflammation plays a pivotal role in the development of atherosclerosis and of its thrombotic complications such as acute coronary syndromes or ischemic stroke. Thus, it has been postulated that the use of anti-inflammatory agents might be extremely useful to improve cardiovascular outcome. Recently, increasing attention has been reserved to one of the oldest plant-derived drugs still in use in clinical practice, colchicine that has been used as drug to treat inflammatory diseases such gout or Mediterranean fever. To date, current guidelines of the European Society of Cardiology have included colchicine as first line choice for treatment of acute and recurrent pericarditis. Moreover, several studies have investigated its role in the clinical scenarios of cardiovascular disease including chronic and acute coronary syndromes with promising results. In this review, starting from a description of the mechanism(s) involved behind its anti-inflammatory effects, we give an overview on its potential effects in atherothrombosis and finally present an updated overview of clinical evidence on the role of this drug in cardiovascular disease.<\/jats:p>","DOI":"10.3390\/ijms24032483","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T04:31:27Z","timestamp":1675053087000},"page":"2483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-7052","authenticated-orcid":false,"given":"Giovanni","family":"Cimmino","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, Section of Cardiology, University of Campania Luigi Vanvitelli, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco S.","family":"Loffredo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Section of Cardiology, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Section of Cardiology, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-4952","authenticated-orcid":false,"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Section of Cardiology, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014From experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kaura, A., Hartley, A., Panoulas, V., Glampson, B., Shah, A.S.V., Davies, J., Mulla, A., Woods, K., Omigie, J., and Thursz, M.R. (2022). Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1003911"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"745061","DOI":"10.3389\/fphar.2021.745061","article-title":"Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"589654","DOI":"10.3389\/fimmu.2020.589654","article-title":"Targeting IL-1beta in the Treatment of Atherosclerosis","volume":"11","author":"Mai","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovas-cular events: Rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory Action of Statins in Cardiovascular Disease: The Role of Inflammasome and Toll-Like Receptor Pathways","volume":"60","author":"Koushki","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_8","first-page":"e18273","article-title":"The Effect of Statin Therapy on Inflammatory Biomarkers: A Systematic Review","volume":"13","author":"Proute","year":"2021","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/eurheartj\/ehz008","article-title":"Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis","volume":"40","author":"Vromman","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1189\/jlb.0208123","article-title":"C-reactive protein (CRP) induces chemokine se-cretion via CD11b\/ICAM-1 interaction in human adherent monocytes","volume":"84","author":"Montecucco","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/00016340802322265","article-title":"Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia","volume":"87","author":"Portelinha","year":"2008","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clinbiochem.2007.09.001","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes","volume":"41","author":"Postadzhiyan","year":"2008","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cardiores.2005.05.010","article-title":"C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation","volume":"68","author":"Cirillo","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/dna.2010.1093","article-title":"C-Reactive Protein Can Influence the Proliferation, Apoptosis, and Monocyte Chemotactic Protein-1 Production of Human Umbilical Vein Endothelial Cells","volume":"30","author":"Guo","year":"2011","journal-title":"DNA Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijcard.2012.10.040","article-title":"C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture","volume":"168","author":"Cimmino","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehq390","article-title":"Platelets release matrix metallopro-teinase-2 in the coronary circulation of patients with acute coronary syndromes: Possible role in sustained platelet activa-tion","volume":"32","author":"Gresele","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jlb.53.4.439","article-title":"C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages","volume":"53","author":"Wiktorowicz","year":"1993","journal-title":"J. Leukoc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.fjc.0000183568.48389.a1","article-title":"C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes","volume":"46","author":"Xie","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0008-6363(02)00855-6","article-title":"Vascular smooth muscle cell activation by C-reactive protein","volume":"58","author":"Hattori","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.113.007124","article-title":"Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: In vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy","volume":"130","author":"Thiele","year":"2014","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s12265-012-9410-7","article-title":"Communication in the heart: The role of the innate immune system in coordinating cellular re-sponses to ischemic injury","volume":"5","author":"Epelman","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCULATIONAHA.105.537712","article-title":"Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: Evidence for a local, intracoronary immunologic mechanism","volume":"113","author":"Abbate","year":"2006","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-Cell Proliferation and Plaque Instability in Acute Coronary Syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.100.21.2135","article-title":"Perturbation of the T-Cell Repertoire in Patients With Unstable Angina","volume":"100","author":"Liuzzo","year":"1999","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12265-015-9608-6","article-title":"Function of CD147 in Atherosclerosis and Atherothrombosis","volume":"8","author":"Wang","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"The Cellular Biology of Macrophages in Atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.114.305144","article-title":"Lymphocytes in Atherosclerosis","volume":"35","author":"Hedrick","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1160\/TH11-05-0321","article-title":"Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall","volume":"106","author":"Ketelhuth","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/intimm\/dxt043","article-title":"T cells in atherosclerosis","volume":"25","author":"Tse","year":"2013","journal-title":"Int. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0952-7915(95)80117-0","article-title":"T-cell regulation of macrophage function","volume":"7","author":"Doherty","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: Old and New","volume":"128","author":"Slobodnick","year":"2014","journal-title":"Am. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Michalkova, R., Mirossay, L., Gazdova, M., Kello, M., and Mojzis, J. (2021). Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones. Cancers, 13.","DOI":"10.3390\/cancers13112730"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijwd.2014.12.004","article-title":"Oleoma treated with oral colchicine: Report of two cases and review of the literature","volume":"1","author":"Lym","year":"2015","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_39","unstructured":"Ben-Chetrit, E. (2018). Textbook of Autoinflammation, Springer."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Man-agement of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients with an Acute Coronary Syndrome","volume":"4","author":"Robertson","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardio-vascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00392-021-01828-9","article-title":"Colchicine in ischemic heart disease: The good, the bad and the ugly","volume":"110","author":"Cappetta","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0021-9258(17)40631-4","article-title":"Podophyllotoxin as a probe for the colchicine binding site of tubulin","volume":"252","author":"Cortese","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/bi00122a020","article-title":"Effect of B-ring substituents on absorption and circular dichroic spectra of colchicine analogues","volume":"31","author":"Pyles","year":"1992","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine Pharmacokinetics and Mechanism of Action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10753-015-0237-7","article-title":"Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: A Pilot Study in Healthy Subjects","volume":"39","author":"Shah","year":"2015","journal-title":"Inflammation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00011-022-01540-y","article-title":"Colchicine for COVID-19: Targeting NLRP3 inflammasome to blunt hyperinflammation","volume":"71","author":"Bonaventura","year":"2022","journal-title":"Inflamm. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The Inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"ref_51","first-page":"3","article-title":"Inflammasomes: Caspase-1-Activating Platforms with Critical Roles in Host Defense","volume":"2","author":"Walle","year":"2011","journal-title":"Front. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: Host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout: Implications for therapy","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","article-title":"Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis","volume":"24","author":"Shi","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e003031","DOI":"10.1161\/JAHA.115.003031","article-title":"NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis","volume":"5","author":"Folkersen","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute cor-onary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mito-chondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"012012","DOI":"10.1088\/1742-6596\/2269\/1\/012012","article-title":"Evaluation of Colchicine\u2019s interaction with the ATP-binding region of mice NLRP3-NACHT domain using molecular docking and dynamics simulation","volume":"2269","author":"Lai","year":"2022","journal-title":"J. Phys. Conf. Ser."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: Implications for its therapeutic action","volume":"163","author":"Chaves","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gonzalez, L., Bulnes, J.F., Orellana, M.P., Munoz Venturelli, P., and Martinez Rodriguez, G. (2022). The Role of Colchicine in Ather-osclerosis: From Bench to Bedside. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071395"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0003319720987752","article-title":"Endothelial Dysfunction and Its Clinical Implications","volume":"72","author":"Poredos","year":"2021","journal-title":"Angiology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00296-013-2681-8","article-title":"Evaluation of circulating endothelial biomarkers in familial Med-iterranean fever","volume":"33","author":"Pamuk","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and pathophysiology of oxLDL uptake by vascular wall cells in ath-erosclerosis","volume":"84","author":"Formoso","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of Ox-LDL and LOX-1 in Atherogenesis","volume":"26","author":"Kanuri","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcp.2016.12.016","article-title":"Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-kappaB","volume":"128","author":"Cirillo","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"106822","DOI":"10.1016\/j.vph.2020.106822","article-title":"Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells","volume":"137","author":"Cimmino","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/cdt.2018.10.14","article-title":"Tissue factor: Newer concepts in thrombosis and its role beyond thrombosis and hemostasis","volume":"8","author":"Cimmino","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2006-10-050476","article-title":"Tissue factor trafficking in fibroblasts: Involvement of protease-activated re-ceptor-mediated cell signaling","volume":"110","author":"Mandal","year":"2007","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0955-0674(00)00123-X","article-title":"Connecting vesicle transport to the cytoskeleton","volume":"12","author":"Kamal","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/cbin.10988","article-title":"Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases","volume":"42","author":"Chaldakov","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0038-1657623","article-title":"Regulation of the Tissue Factor Gene","volume":"78","author":"Mackman","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_75","first-page":"341","article-title":"Nuclear transcription factor NF-kappa B: Role in biology and medicine","volume":"42","author":"Aggarwal","year":"2004","journal-title":"Experiment"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/j.yexcr.2009.08.020","article-title":"Microtubule-mediated NF-kappaB activation in the TNF-alpha signaling pathway","volume":"315","author":"Jackman","year":"2009","journal-title":"Exp. Cell Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lfs.2018.02.024","article-title":"LOX-1 receptor: A potential link in atherosclerosis and cancer","volume":"198","author":"Balzan","year":"2018","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"152786","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Mehta","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.20.4.1116","article-title":"Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: Evidence from use of antisense LOX-1 mRNA and chemical inhib-itors","volume":"20","author":"Li","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/cvr\/cvz230","article-title":"Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1","volume":"116","author":"Cimmino","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.7150\/ijbs.49871","article-title":"Role of smooth muscle cells in Cardiovascular Disease","volume":"16","author":"Zhuge","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.89.5.1929","article-title":"Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells","volume":"89","author":"March","year":"1994","journal-title":"Circulation"},{"key":"ref_84","first-page":"531","article-title":"Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy","volume":"5","author":"Bauriedel","year":"1994","journal-title":"Coron. Artery Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.109.208389","article-title":"Vascular smooth muscle cell apoptosis induces interleukin-1-directed in-flammation: Effects of hyperlipidemia-mediated inhibition of phagocytosis","volume":"106","author":"Clarke","year":"2010","journal-title":"Circ. Res."},{"key":"ref_86","first-page":"107","article-title":"Effect of trifluoperazine and colchicine on smooth muscle cellular proliferative and secretory activity induced by hypercholesterolemic medium in vitro","volume":"21","author":"Mehta","year":"1990","journal-title":"Biochem. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0306-9877(98)90031-7","article-title":"Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases?","volume":"51","author":"Levy","year":"1998","journal-title":"Med. Hypotheses."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: A rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.hlc.2016.06.210","article-title":"Pro-Inflammatory Effects of Col-chicine on Macrophages Stimulated with Atherogenic Stimuli In Vitro","volume":"25","author":"Schwarz","year":"2016","journal-title":"Heart Lung Circ."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"898690","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation","volume":"13","author":"Mauersberger","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.imbio.2016.05.010","article-title":"Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells","volume":"221","author":"Chistiakov","year":"2016","journal-title":"Immunobiology"},{"key":"ref_93","first-page":"349","article-title":"Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: An insight into the cellular mechanisms associated to plaque desta-bilization","volume":"54","author":"Profumo","year":"2013","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.108.182428","article-title":"T-Cell Costimulation and Coinhibition in Atherosclerosis","volume":"103","author":"Gotsman","year":"2008","journal-title":"Circ. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2016.04.177","article-title":"Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis?","volume":"218","author":"Cirillo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11883-008-0037-8","article-title":"The complex role of T-cell-based immunity in atherosclerosis","volume":"10","author":"Aukrust","year":"2008","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1073\/pnas.74.8.3404","article-title":"Effects of colchicine on cyclic AMP levels in human leukocytes","volume":"74","author":"Rudolph","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hep.1840110208","article-title":"Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis","volume":"11","author":"Kershenobich","year":"1990","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11239-021-02585-2","article-title":"Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes","volume":"53","author":"Cirillo","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2020.07.008","article-title":"Platelets and coagulation factors: Established and novel roles in atherosclerosis and athero-thrombosis","volume":"307","author":"Koenen","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1172\/JCI109855","article-title":"Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187","volume":"66","author":"Menche","year":"1980","journal-title":"J. Clin. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vph.2018.09.004","article-title":"Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1","volume":"111","author":"Cimmino","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.tcb.2019.07.004","article-title":"Microtubule-Associated Proteins: Structuring the Cytoskeleton","volume":"29","author":"Bodakuntla","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_104","first-page":"339","article-title":"Cofilin\u2014A protein controlling dynamics of actin filaments","volume":"71","author":"Ostrowska","year":"2017","journal-title":"Adv. Hyg. Exp. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11239-020-02121-8","article-title":"Effects of colchicine on platelet ag-gregation in patients on dual antiplatelet therapy with aspirin and clopidogrel","volume":"50","author":"Cirillo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejim.2012.04.007","article-title":"Mean platelet volume and beta-thromboglobulin levels in familial Mediterranean fever: Effect of colchicine use?","volume":"23","author":"Abanonu","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil ex-tracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","article-title":"The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis","volume":"288","author":"Moschonas","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdermsci.2018.08.010","article-title":"Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behcet\u2019s disease","volume":"92","author":"Safi","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e018993","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients with Acute Coronary Syndrome after Percuta-neous Coronary Intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_111","first-page":"9","article-title":"Prevalence of ischemic heart disease in patients with familial Mediterranean fever","volume":"3","author":"Langevitz","year":"2001","journal-title":"Isr. Med Assoc. J. IMAJ"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.cjca.2020.05.026","article-title":"Colchicine Use and Incident Coronary Artery Disease in Male Patients with Gout","volume":"36","author":"Shah","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: A cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The Low Dose Colchicine after Myocardial In-farction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am. Heart J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000512772","article-title":"Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol\u2014The COVERT-MI Study","volume":"146","author":"Bresson","year":"2021","journal-title":"Cardiology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/eurjpc\/zwab045","article-title":"Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: A systematic review and meta-analysis on 12 869 patients","volume":"28","author":"Andreis","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11239-022-02659-9","article-title":"The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: A systematic review and meta-analysis","volume":"54","author":"Goh","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/8317011","article-title":"Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials","volume":"2022","author":"Razavi","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/2396987320972566","article-title":"Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE)\u2014Study protocol for a randomised controlled trial","volume":"6","author":"Kelly","year":"2021","journal-title":"Eur. Stroke J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:17:13Z","timestamp":1760120233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":124,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032483"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032483","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]}}}